Literature DB >> 29192539

Experimental chronic cerebral hypoperfusion results in decreased pericyte coverage and increased blood-brain barrier permeability in the corpus callosum.

Qinghai Liu1, Ryan Radwanski1, Robin Babadjouni1, Arati Patel1, Drew M Hodis1, Peter Baumbacher1, Zhen Zhao1, Berislav Zlokovic1, William J Mack1,2.   

Abstract

Murine chronic cerebral hypoperfusion (CCH) results in white matter (WM) injury and behavioral deficits. Pericytes influence blood-brain barrier (BBB) integrity and cerebral blood flow. Under hypoxic conditions, pericytes detach from perivascular locations increasing vessel permeability and neuronal injury. This study characterizes the time course of BBB dysfunction and pericyte coverage following murine experimental CCH secondary to bilateral carotid artery stenosis (BCAS). Mice underwent BCAS or sham operation. On post-procedure days 1, 3, 7 and 30, corpus callosum BBB permeability was characterized using Evans blue (EB) extravasation and IgG staining and pericyte coverage/count was calculated. The BCAS cohort demonstrated increased EB extravasation on postoperative days 1 ( p = 0.003) 3 ( p = 0.002), and 7 ( p = 0.001) when compared to sham mice. Further, EB extravasation was significantly greater ( p = 0.05) at day 3 than at day 30 in BCAS mice. BCAS mice demonstrated a nadir in pericyte coverage and count on post-operative day 3 ( p < 0.05, compared to day 7, day 30 and sham). Decreased pericyte coverage/count and increased BBB permeability are most pronounced on postoperative day 3 following murine CCH. This precedes any notable WM injury or behavioral deficits.

Entities:  

Keywords:  Carotid stenosis; hypoperfusion; pericyte; permeability; white matter

Mesh:

Year:  2017        PMID: 29192539      PMCID: PMC6365610          DOI: 10.1177/0271678X17743670

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  43 in total

1.  Pericytes regulate the blood-brain barrier.

Authors:  Annika Armulik; Guillem Genové; Maarja Mäe; Maya H Nisancioglu; Elisabet Wallgard; Colin Niaudet; Liqun He; Jenny Norlin; Per Lindblom; Karin Strittmatter; Bengt R Johansson; Christer Betsholtz
Journal:  Nature       Date:  2010-10-13       Impact factor: 49.962

Review 2.  Dilatative arteriopathy (dolichoectasia): What is known and not known.

Authors:  Louis R Caplan
Journal:  Ann Neurol       Date:  2005-04       Impact factor: 10.422

3.  Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery.

Authors:  Muge Yemisci; Yasemin Gursoy-Ozdemir; Atay Vural; Alp Can; Kamil Topalkara; Turgay Dalkara
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

4.  Pericytes are required for blood-brain barrier integrity during embryogenesis.

Authors:  Richard Daneman; Lu Zhou; Amanuel A Kebede; Ben A Barres
Journal:  Nature       Date:  2010-10-13       Impact factor: 49.962

5.  Angiogenic and vasoprotective effects of adrenomedullin on prevention of cognitive decline after chronic cerebral hypoperfusion in mice.

Authors:  Takakuni Maki; Masafumi Ihara; Youshi Fujita; Takuo Nambu; Kazutoshi Miyashita; Mahito Yamada; Kazuo Washida; Keiko Nishio; Hidefumi Ito; Hiroshi Harada; Hideki Yokoi; Hiroshi Arai; Hiroshi Itoh; Kazuwa Nakao; Ryosuke Takahashi; Hidekazu Tomimoto
Journal:  Stroke       Date:  2011-03-10       Impact factor: 7.914

6.  Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity.

Authors:  Tailoi Chan-Ling; Matthew Philip Page; Tom Gardiner; Louise Baxter; Emilia Rosinova; Suzanne Hughes
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

7.  Mfsd2a is critical for the formation and function of the blood-brain barrier.

Authors:  Ayal Ben-Zvi; Baptiste Lacoste; Esther Kur; Benjamin J Andreone; Yoav Mayshar; Han Yan; Chenghua Gu
Journal:  Nature       Date:  2014-05-14       Impact factor: 49.962

Review 8.  Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Pharmacol Biochem Behav       Date:  2007-05-04       Impact factor: 3.533

9.  Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation.

Authors:  Ayman ElAli; Peter Thériault; Paul Préfontaine; Serge Rivest
Journal:  Acta Neuropathol Commun       Date:  2013-11-13       Impact factor: 7.801

Review 10.  Global epidemiology of dementia: Alzheimer's and vascular types.

Authors:  Liara Rizzi; Idiane Rosset; Matheus Roriz-Cruz
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

View more
  31 in total

Review 1.  Multifaceted roles of pericytes in central nervous system homeostasis and disease.

Authors:  Zhitong Zheng; Michael Chopp; Jieli Chen
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-24       Impact factor: 6.200

Review 2.  Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?

Authors:  Corey J Frank; Ewan C McNay
Journal:  J Neuroendocrinol       Date:  2021-12-13       Impact factor: 3.627

Review 3.  Understanding the role of the perivascular space in cerebral small vessel disease.

Authors:  Rosalind Brown; Helene Benveniste; Sandra E Black; Serge Charpak; Martin Dichgans; Anne Joutel; Maiken Nedergaard; Kenneth J Smith; Berislav V Zlokovic; Joanna M Wardlaw
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

4.  Protective effects of edaravone on white matter pathology in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion.

Authors:  Tian Feng; Toru Yamashita; Ryo Sasaki; Koh Tadokoro; Namiko Matsumoto; Nozomi Hishikawa; Koji Abe
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-26       Impact factor: 6.200

5.  Connexin43 promotes angiogenesis through activating the HIF-1α/VEGF signaling pathway under chronic cerebral hypoperfusion.

Authors:  Weiwei Yu; Haiqiang Jin; Wei Sun; Ding Nan; Jianwen Deng; Jingjing Jia; Zemou Yu; Yining Huang
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-25       Impact factor: 6.200

6.  Integrative analysis of the human brain mural cell transcriptome.

Authors:  Benjamin D Gastfriend; Koji L Foreman; Moriah E Katt; Sean P Palecek; Eric V Shusta
Journal:  J Cereb Blood Flow Metab       Date:  2021-05-22       Impact factor: 6.200

7.  Modeling hyperosmotic blood-brain barrier opening within human tissue-engineered in vitro brain microvessels.

Authors:  Raleigh M Linville; Jackson G DeStefano; Matt B Sklar; Chengyan Chu; Piotr Walczak; Peter C Searson
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-08       Impact factor: 6.960

Review 8.  Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia.

Authors:  Tuo Yang; Feng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

9.  Distinct signatures of calcium activity in brain mural cells.

Authors:  Chaim Glück; Kim David Ferrari; Noemi Binini; Annika Keller; Aiman S Saab; Jillian L Stobart; Bruno Weber
Journal:  Elife       Date:  2021-07-06       Impact factor: 8.140

10.  Tropisetron But Not Granisetron Ameliorates Spatial Memory Impairment Induced by Chronic Cerebral Hypoperfusion.

Authors:  Ashkan Divanbeigi; Mohammad Nasehi; Salar Vaseghi; Sepideh Amiri; Mohammad-Reza Zarrindast
Journal:  Neurochem Res       Date:  2020-08-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.